Intracranial hypotension in a breast cancer patient treated with epidural blood patches.

Autor: Minot-This MS; Department of Medical Oncology, Gustave Roussy, Villejuif, 94800, France., Grinda T; Department of Medical Oncology, Gustave Roussy, Villejuif, 94800, France., Epaillard N; Department of Medical Oncology, Gustave Roussy, Villejuif, 94800, France., Guyon D; Department of Medical Oncology, Gustave Roussy, Villejuif, 94800, France., Jawiche RE; Department of Anaesthesia, Gustave Roussy, Villejuif, 94800, France., Garcia G; Department of Radiology, Gustave Roussy, Villejuif, 94800, France., Pistilli B; Department of Medical Oncology, Gustave Roussy, Villejuif, 94800, France.

Publikováno v: CNS oncology [CNS Oncol] 2023 Mar 01; Vol. 12 (1), pp. CNS94. Date of Electronic Publication: 2023 Mar 06.

Relation between Plasma Trough Concentration of Pazopanib and Progression-Free Survival in Metastatic Soft Tissue Sarcoma Patients.

Autor: Minot-This MS; Institut du Cancer Paris CARPEM, AP-HP, APHP.Centre, Department of Medical Oncology, ARIANE, Cochin Hospital, 75014 Paris, France., Boudou-Rouquette P; Institut du Cancer Paris CARPEM, AP-HP, APHP.Centre, Department of Medical Oncology, ARIANE, Cochin Hospital, 75014 Paris, France., Jouinot A; Institut du Cancer Paris CARPEM, AP-HP, APHP.Centre, Department of Medical Oncology, ARIANE, Cochin Hospital, 75014 Paris, France.; INSERM U-1016, CNRS UMR-8104, University of Paris, Institut Cochin, 75014 Paris, France., de Percin S; Institut du Cancer Paris CARPEM, AP-HP, APHP.Centre, Department of Medical Oncology, ARIANE, Cochin Hospital, 75014 Paris, France., Balakirouchenane D; Department of Pharmacokinetics and Pharmacochemistry, AP-HP, CARPEM, Cochin Hospital, 75014 Paris, France.; UMR8038 CNRS, U1268 INSERM, Faculty of Pharmacy, University of Paris, PRES Sorbonne Paris Cité, CARPEM, 75006 Paris, France., Khoudour N; Department of Pharmacokinetics and Pharmacochemistry, AP-HP, CARPEM, Cochin Hospital, 75014 Paris, France., Tlemsani C; Institut du Cancer Paris CARPEM, AP-HP, APHP.Centre, Department of Medical Oncology, ARIANE, Cochin Hospital, 75014 Paris, France., Chauvin J; Lixoft, 92160 Antony, France., Thomas-Schoemann A; Department of Pharmacokinetics and Pharmacochemistry, AP-HP, CARPEM, Cochin Hospital, 75014 Paris, France.; UMR8038 CNRS, U1268 INSERM, Faculty of Pharmacy, University of Paris, PRES Sorbonne Paris Cité, CARPEM, 75006 Paris, France., Goldwasser F; Institut du Cancer Paris CARPEM, AP-HP, APHP.Centre, Department of Medical Oncology, ARIANE, Cochin Hospital, 75014 Paris, France.; Lixoft, 92160 Antony, France., Blanchet B; Department of Pharmacokinetics and Pharmacochemistry, AP-HP, CARPEM, Cochin Hospital, 75014 Paris, France.; UMR8038 CNRS, U1268 INSERM, Faculty of Pharmacy, University of Paris, PRES Sorbonne Paris Cité, CARPEM, 75006 Paris, France., Alexandre J; Institut du Cancer Paris CARPEM, AP-HP, APHP.Centre, Department of Medical Oncology, ARIANE, Cochin Hospital, 75014 Paris, France.; Centre de Recherche des Cordeliers, Université Paris-Sorbonne, INSERM, 75005 Paris, France.

Publikováno v: Pharmaceutics [Pharmaceutics] 2022 Jun 09; Vol. 14 (6). Date of Electronic Publication: 2022 Jun 09.

[New approval: Atezolizumab and bevacizumab for first line of unresecable hepatocellular carcinoma].

Autor: Minot-This MS; Institut Gustave-Roussy, Sorbonne Université, service d'oncologie digestive, 94800 Villejuif, France. Electronic address: ms.minot@gmail.com., Edeline J; Centre hospitalier universitaire de Rennes, centre Eugène-Marquis, service d'oncologie digestive, 35000 Rennes, France.

Publikováno v: Bulletin du cancer [Bull Cancer] 2021 Feb; Vol. 108 (2), pp. 139-140. Date of Electronic Publication: 2021 Feb 02.